Here are five insights:
1. The initiative will emphasize risks associated with opioids as well as pain management alternatives to opioids.
2. Parsippany-Troy Hills, N.J.-based Pacira Pharmaceuticals offered ACS an education grant, which the society will use to create Opioids and Surgery: Use, Abuse and Alternatives, materials for professional and patient education.
3. Surgeons will be able to access resources on opioids and managing pain expectations as well as non-opioid alternatives and screening programs.
4. The resources will also emphasize team training in pain management, discharge and transition management.
5. ACS hopes this program will help develop a national standard for best intervention methods for pain control.
More articles on quality & infection control:
EpiPen may find competition in Auvi-Q’s relaunch, but will prices continue to soar? — 4 points
Is Zika becoming an endemic disease in the US? 6 things to know
NPs & PAs prescription of antibiotics on the uptick: 5 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
